IRIDEX Management

Management criteria checks 3/4

IRIDEX's CEO is Patrick Mercer, appointed in May 2024, has a tenure of less than a year. total yearly compensation is $518.07K, comprised of 64.9% salary and 35.1% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth $108.65K. The average tenure of the management team and the board of directors is 0.5 years and 5.6 years respectively.

Key information

Patrick Mercer

Chief executive officer

US$518.1k

Total compensation

CEO salary percentage64.9%
CEO tenureless than a year
CEO ownership0.4%
Management average tenureless than a year
Board average tenure5.6yrs

Recent management updates

Recent updates

Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

Jun 11
Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

May 14
Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 28

Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

Feb 14
Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Oct 04
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

Aug 12
Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Apr 14
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Oct 12
We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Feb 25
Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Iridex To Benefit From New Revolutionary Glaucoma Treatment

Jan 11

Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long

Jan 03
Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long

IRIDEX says laser therapy now accepted in the European Glaucoma Society guidelines

Dec 23

CEO Compensation Analysis

How has Patrick Mercer's remuneration changed compared to IRIDEX's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 28 2024n/an/a

-US$11m

Jun 29 2024n/an/a

-US$11m

Mar 30 2024n/an/a

-US$11m

Dec 30 2023US$518kUS$336k

-US$10m

Sep 30 2023n/an/a

-US$8m

Jul 01 2023n/an/a

-US$8m

Apr 01 2023n/an/a

-US$7m

Dec 31 2022US$568kUS$317k

-US$8m

Oct 01 2022n/an/a

-US$9m

Jul 02 2022n/an/a

-US$9m

Apr 02 2022n/an/a

-US$6m

Jan 01 2022US$765kUS$317k

-US$5m

Oct 02 2021n/an/a

-US$3m

Jul 03 2021n/an/a

-US$3m

Apr 03 2021n/an/a

-US$7m

Jan 02 2021US$472kUS$316k

-US$6m

Sep 26 2020n/an/a

-US$8m

Jun 27 2020n/an/a

-US$8m

Mar 28 2020n/an/a

-US$7m

Dec 28 2019US$500kUS$277k

-US$9m

Compensation vs Market: Patrick's total compensation ($USD518.07K) is about average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Patrick's compensation has been consistent with company performance over the past year.


CEO

Patrick Mercer (52 yo)

less than a year

Tenure

US$518,073

Compensation

Mr. Patrick Mercer is Chief Executive Officer of IRIDEX Corporation from October 1, 2024 and serves as it's President since May 22, 2024 and was its Chief Operating Officer since September 2018 until Octob...


Leadership Team

NamePositionTenureCompensationOwnership
Scott Shuda
Executive Chairman5.6yrsUS$154.00k0.41%
$ 121.8k
Patrick Mercer
CEO & Presidentless than a yearUS$518.07k0.37%
$ 108.7k
Fuad Ahmad
Interim Chief Financial Officer4yrsUS$356.84kno data
Leigh Salvo
Head of Investor Relationsno datano datano data

0.5yrs

Average Tenure

54yo

Average Age

Experienced Management: IRIX's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Scott Shuda
Executive Chairman5.6yrsUS$154.00k0.41%
$ 121.8k
Beverly Huss
Independent Director2.7yrsUS$127.50k0.17%
$ 48.6k
Kenneth Ludlum
Independent Director5.6yrsUS$134.50k0.38%
$ 110.5k
Robert Grove
Independent Director6.1yrsUS$119.00k0.73%
$ 213.9k

5.6yrs

Average Tenure

67yo

Average Age

Experienced Board: IRIX's board of directors are considered experienced (5.6 years average tenure).